(sphingotec GmbH) Data from more than 2,000 patients enrolled in the FROG-ICU study demonstrate that high levels of bioactive adrenomedullin (bio-ADM®) predict the need for organ support, ionotropes, and vasopressors in the general patient population at admission to the intensive care unit (ICU).

Original source: https://www.eurekalert.org/pub_releases/2019-12/sg-sef122019.php